Site menu

Search by ticker code:
Generic filters


Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

Pro Medicus (ASX:PME) share price soars after impressive FY23 result

The Pro Medicus Ltd (ASX: PME) share price has gained another 5% following the FY23 result which included more impressive growth.

Pro Medicus calls itself a leading healthcare informatics company, providing a full range of medical imaging software and services to hospitals, imaging centres and healthcare groups worldwide.

FY23 report

Here are some of the main highlights from the 12 months to June 2023:

The company declared a final dividend per share of $0.17, which was an increase of 36.4%.

Pro Medicus was pleased to say that eight of its key (client) implementations were completed within planned timeframes which helped “clear the deck” so that it can implement contracts it has recently won.

The ASX share is now providing imaging solutions to nine of the top 22 US hospitals, which is more than any other competitor.

Outlook for the Pro Medicus share price

Pro Medicus noted that its pipeline remains “strong in all market segments”, with trends that are driving the industry continuing unabated. Pro Medicus Dr Sam Hupert said:

Exponentially larger data sets, the transition to cloud and the acute global shortage of radiologists create demands that are uniquely satisfied by our Visage technology.

Hupert also revealed it expects that its EBIT margin to “broadly remain around these levels”. It was approximately 67% in the FY23 result.

USA, Europe and Australia all saw underlying growth in FY23 and I think the company will continue to generate growth in the year(s) ahead.

It’s also looking to expand in the cardiology space as well as utilise AI. It’s targeting its first commercialisation in these areas within the next six months.

Pro Medicus is a wonderful business and it keeps growing profit, which improves the underlying value of the business. However, it’s hard to say today’s valuation is attractive considering the price/earnings ratio (p/e ratio) that it’s now valued at. There are plenty of ASX growth shares that I’d rather pick for my portfolio at today’s share prices.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, Jaz does not have a financial or commercial interest in any of the companies mentioned.
Skip to content